MedPath

A Needs-focused Palliative Care Intervention for Older Adults in ICUs

Not Applicable
Completed
Conditions
Care Delivery Model
Palliative Care
Informal Caregivers
Aging
Critical Illness
Psychological Distress
Interventions
Behavioral: PCplanner
Registration Number
NCT04414787
Lead Sponsor
Duke University
Brief Summary

The quality of intensive care unit (ICU)-based palliative care is highly variable, particularly for the 2 million older adults admitted annually to ICUs. To address these care delivery barriers among older ICU patients, a mobile app platform called PCplanner (Palliative Care planner) was developed. PCplanner automates the identification of high-risk patients (e.g., dementia, declining health status, poor functioning) by directly capturing data from electronic health record (EHR) systems, cultivates family engagement with supportive information and a digital system for self-report of actual needs, and facilitates the delivery of care to those with a high burden of need by coordinating collaboration between ICU teams and palliative care specialists.

150 patients, 150 family caregivers, and 75 physicians from academic and community settings will be enrolled in a RCT designed to test the efficacy of PCplanner-augmented collaborative palliative care vs usual care. Family caregiver and clinician experiences will be explored using mixed methods to understand intervention mechanisms as well as implementation barriers within diverse case contexts. The key hypothesis is that compared to usual care, PCplanner will reduce family caregivers' unmet needs and psychological distress, increase the frequency of goal concordant treatment among older adult patients, and reduce hospital length of stay.

Detailed Description

The quality of intensive care unit (ICU)-based palliative care is highly variable, particularly for the 2 million older adults admitted annually to ICUs. However, improving care quality on a broad scale with the efficient delivery of patient-centered, need-targeted palliative care is challenging because of logistical and technological barriers. To address these care delivery barriers among older ICU patients, a mobile app platform called PCplanner (Palliative Care planner) was developed. PCplanner automates the identification of high-risk patients (e.g., dementia, declining health status, poor functioning) by directly capturing data from electronic health record (EHR) systems, cultivates family engagement with supportive information and a digital system for self-report of actual needs, and facilitates the delivery of care to those with a high burden of need by coordinating collaboration between ICU teams and palliative care specialists. In pilot comparison to a standard palliative care control, the intervention reduced unmet needs, psychological distress, and length of stay and increased goal concordant care, communication, and hospice utilization.

While these data are compelling, an efficacy evaluation of PCplanner is needed. Therefore, 150 patients, 150 family caregivers, and 75 physicians will be enrolled from academic and community settings in a project with 2 key aims: (1) Test the efficacy of PCplanner-augmented collaborative palliative care vs usual care in a randomized clinical trial (RCT) with 3-month follow up, and (2) Explore family caregiver and clinician experiences using mixed methods to understand intervention mechanisms as well as implementation barriers within diverse case contexts. The key hypothesis is that compared to usual care, PCplanner will reduce family caregivers' unmet needs and psychological distress, increase the frequency of goal concordant treatment among older adult patients, and reduce hospital length of stay.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
152
Inclusion Criteria
  • ≥50 years of age
  • Receive care in a study ICU for ≥24 hours
  • Meets ≥1 of 9 high risk phenotypes a. Dementia (e.g., Alzheimer's, multi-infarct, other dementia etiology) b. Declining health status defined by EITHER: i. ≥2 hospital admissions in 3 months preceding current admission OR ii. >1 ICU admission in 3 months preceding current admission c. Poor functional status defined by EITHER: i. admit from Skilled Nursing Facility (SNF) or Long-Term Acute Care (LTAC) facility OR ii. ≥3 activities of daily living (ADL) limitations at admission d. Severe acute illness defined by EITHER: i. cardiac arrest OR ii. multisystem organ failure (≥3 of: lung, kidney, hematological, brain, cardiac, liver) that has worsened over 48 hours (i.e., Sequential Organ Failure Assessment [SOFA] score increase) e. Severe acute stroke (e.g., acute intracranial hemorrhage, ischemic stroke, or traumatic brain injury) f. Acute respiratory failure (ventilation or high oxygen support for ≥24 hours) g. Acute renal failure (new hemodialysis or continuous venovenous hemodiafiltration for ≥1 hour) h. Advanced cancer (Advanced / metastatic cancer diagnosis) i. Shock (use of vasopressor or inotrope for ≥4 hours)

Exclusion Criteria (pre-consent):

  • Palliative care consultation performed during the hospitalization before eligibility determination
  • Current admission to ICU at the index hospital ≥8 days
  • Imprisoned
  • No known family or surrogate decision maker
  • Death expected within 24 hours

Exclusion Criteria (post-consent):

  • Patient dies before T2

FAMILY MEMBER

Inclusion Criteria:

  • ≥18 years of age
  • Self-described as the individual (related or unrelated) who provides the most support and with whom the patient has a significant relationship (per definition of 'family' described in the Society of Critical Care Medicine 2016 Guidelines for Family-Centered Care in the Neonatal, Pediatric, and Adult ICU)

Exclusion Criteria (pre-consent):

  • Lack a knowledge of English such that the potential participant is not confident that they could complete study tasks (app viewing, surveys)
  • Imprisoned
  • Unable to complete surveys for any reason

Exclusion Criteria (post-consent):

  • Low need burden (NEST score <10) at baseline

ICU PHYSICIANS

Inclusion Criteria:

  • ≥18 years of age
  • Attending or fellow physician in a study ICU
Read More
Exclusion Criteria
  • None
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionPCplannerPCplanner intervention during hospitalization
Primary Outcome Measures
NameTimeMethod
Needs; Existential concerns; Symptoms; and Therapeutic interaction (NEST) scale total scoreTime 1 (baseline), Time 2 (target ~3 days post-randomization), and Time 3 (target ~1 week post-randomization)

A palliative care needs instrument. Scores range from 0 (no needs) to 130 (higher needs)

Secondary Outcome Measures
NameTimeMethod
Post-randomization intensive care unit length of stayAcross the entire hospitalization after randomization (approximately 2 weeks)

A measure of intensive care unit days after randomization

Patient Health Questionnaire 9-Item scale (PHQ-9)Time 1 (baseline), Time 3 (target ~1 week post-randomization), and Time 4 (3 months post-randomization)

A depression symptoms instrument. Scores range from 0 (no depression symptoms) to 27 (higher depression symptoms)

Goal concordant careTime 1 (baseline), Time 2 (target ~3 days post-randomization), and Time 3 (target ~1 week post-randomization)

A measure of hospital days after randomization

Post-Traumatic Stress Symptom (PTSS) inventoryTime 1 (baseline) and Time 4 (3 months post-randomization)

A post-traumatic stress disorder symptom instrument. Scores range from 10 (low PTSD symptoms) to 70 (higher PTSD symptoms)

Patient-Perceived Patient-Centeredness (PPPC) scaleTime 3 (target ~1 week post-randomization)

A measure of patient-centeredness with scores that range from 12 (higher patient-centeredness) to 48 (lower patient-centeredness)

Generalized Anxiety Disorder 7-Item scale (GAD-7)Time 1 (baseline), Time 3 (target ~1 week post-randomization), and Time 4 (3 months post-randomization)

An anxiety symptoms instrument. Scores range from 0 (no anxiety symptoms) to 21 (higher anxiety symptoms)

Post-randomization hospital length of stayAcross the entire hospitalization after randomization (approximately 2 weeks)

A measure of hospital days after randomization

Trial Locations

Locations (1)

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath